Analyst Ratings For Johnson Matthey (LON:JMAT)
Today, Liberum Capital reiterated its Buy rating on Johnson Matthey (LON:JMAT).
There are 9 Buy Ratings, 1 Sell Ratings, 1 Hold Ratings, no Strong Buy Ratings on the stock.
The current consensus rating on Johnson Matthey (LON:JMAT) is Buy with a consensus target price of GBX 3,747.50 per share, a potential .
Some recent analyst ratings include
- 2/21/2019-Johnson Matthey (LON:JMAT) had its Buy rating reiterated by Liberum Capital
- 1/8/2019-Johnson Matthey (LON:JMAT) had its Buy rating reiterated by HSBC
- 12/12/2018-Johnson Matthey (LON:JMAT) had its Outperform rating reiterated by Credit Suisse Group
- 11/23/2018-Johnson Matthey (LON:JMAT) had its Sell rating reiterated by UBS Group with a GBX 2,750 price target
- 9/17/2018-Johnson Matthey (LON:JMAT) had its Buy rating reiterated by Berenberg Bank with a GBX 4,300 price target
About Johnson Matthey (LON:JMAT)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
Recent Trading Activity for Johnson Matthey (LON:JMAT)
Shares of Johnson Matthey closed the previous trading session at 175,00 −28,00 0,87 % with shares trading hands.
